SDB z31401127 Sonax-Gloss-Shampoo Gb-En
SDB z31401127 Sonax-Gloss-Shampoo Gb-En
SDB z31401127 Sonax-Gloss-Shampoo Gb-En
GHS07
56.0.15
Page 2/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 1)
P302+P352 IF ON SKIN: Wash with plenty of water.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if
present and easy to do. Continue rinsing.
P333+P313 If skin irritation or rash occurs: Get medical advice/attention.
P337+P313 If eye irritation persists: Get medical advice/attention.
P501 Dispose of contents/container in accordance with local/regional/national/international
regulations.
Labelling of packages where the contents do not exceed 125 ml
Marking container <125 ml deviates. Reduced labeling according article 29 and annex I, no. 1.5 GB CLP-
regulation is used.
2.3 Other hazards
Results of PBT and vPvB assessment
PBT:
According to information provided in the supply chain, the mix contains less than 0.1% of any substances
classified as PBT
vPvB:
According to information provided in the supply chain, the mix contains less than 0.1% of any substances
classified as vPvB.
Determination of endocrine-disrupting properties
The substance/mixture does not contain components considered to have endocrine disrupting properties
according to UK REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission
Regulation (EU) 2018/605 at levels of 0.1% or higher.
56.0.15
Page 3/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 2)
After inhalation: Supply fresh air.
After skin contact:
Wash the areas of skin affected with water and a mild detergent.
If symptoms persist consult doctor.
After eye contact:
Rinse opened eye for several minutes under running water. If symptoms persist, consult a doctor.
After swallowing:
Rinse out mouth and then drink plenty of water.
If symptoms persist consult doctor.
4.2 Most important symptoms and effects, both acute and delayed
Eye irritation
sensitization
Allergic reactions
4.3 Indication of any immediate medical attention and special treatment needed
Treatment in accordance with the doctor's assessment of the patient's condition. Symptomatic treatment.
56.0.15
Page 4/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 3)
Recommended storage temperature: 20 °C.
7.3 Specific end use(s) No further relevant information available.
56.0.15
Page 5/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 4)
56.0.15
Page 6/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 5)
LD/LC50 values relevant for classification:
CAS: 68891-38-3 alcohols, C12-14, ethoxylated, sulfates, sodium salts
Oral LD50 >5,000 mg/kg (rat)
Dermal LD 50 >5,000 mg/kg (rat)
CAS: 68439-46-3 C9-11 Alcohol ethoxylate
Oral LD50 >5,000 mg/kg (rat)
Dermal LD50 >2,000 mg/kg (rabbit)
Skin corrosion/irritation Based on available data, the classification criteria are not met.
Serious eye damage/irritation Causes serious eye irritation.
Respiratory or skin sensitisation May cause an allergic skin reaction.
Germ cell mutagenicity Based on available data, the classification criteria are not met.
Carcinogenicity Based on available data, the classification criteria are not met.
Reproductive toxicity Based on available data, the classification criteria are not met.
STOT-single exposure Based on available data, the classification criteria are not met.
STOT-repeated exposure Based on available data, the classification criteria are not met.
Aspiration hazard Based on available data, the classification criteria are not met.
11.2 Information on other hazards
Endocrine disrupting properties
According to the current state of scientific knowledge, there is no data for the product regarding endocrine
disrupting properties with health effects.
None of the ingredients is listed.
56.0.15
Page 7/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 6)
12.2 Persistence and degradability
The surface-active substances contained in the product meet the requirement of the EU Detregent Regulation
( EC/648/2004 ) for ultimate biodegradability for surfactants in detergents.
CAS: 3811-73-2 pyridine-2-thiol 1-oxide, sodium salt
Biodegradation >70 % (activated sludge) (OECD 301 B)
12.3 Bioaccumulative potential
CAS: 2682-20-4 2-methylisothiazol-3(2H)-one
BCF 3.16
log Kow ≤0.32
CAS: 3811-73-2 pyridine-2-thiol 1-oxide, sodium salt
log Kow <-1.09 ((n-Octanol/Wasser) OECD 107)
12.4 Mobility in soil No further relevant information available.
12.5 Results of PBT and vPvB assessment
PBT:
According to information provided in the supply chain, the mix conatins less than 0.1% of any substances
classified as PBT
vPvB:
According to information provided in the supply chain, the mix conatins less than 0.1% of any substances
classified as vPvB
12.6 Endocrine disrupting properties
According to the current state of scientific knowledge, there is no data for the product regarding endocrine
disrupting properties with effects on the environment.
12.7 Other adverse effects
Additional ecological information:
General notes:
The product may not be released into the environment without control.
The product does not contain organically bounded halogens (AOX-free).
The product does not contain organic complexing agents.
56.0.15
Page 8/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 7)
56.0.15
Page 9/9
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 15.12.2023 Version: 11.00 (replaces version 10.00) Revision: 19.10.2023
(Contd. of page 8)
Abbreviations and acronyms:
NOEL = No Observed Effect Level
NOEC = No Observed Effect Concentration
LC = letal Concentration
EC50 = half maximal effective concentration
log POW = Octanol / water partition coefficient
GHS: Globally Harmonized System of Classification and Labelling of Chemicals
ATE: acute toxicity estimate
ADR: Accord relatif au transport international des marchandises dangereuses par route (European Agreement Concerning the International
Carriage of Dangerous Goods by Road)
IMDG: International Maritime Code for Dangerous Goods
IATA: International Air Transport Association
EINECS: European Inventory of Existing Commercial Chemical Substances
ELINCS: European List of Notified Chemical Substances
CAS: Chemical Abstracts Service (division of the American Chemical Society)
DNEL: Derived No-Effect Level (UK REACH)
PNEC: Predicted No-Effect Concentration (UK REACH)
LC50: Lethal concentration, 50 percent
LD50: Lethal dose, 50 percent
IOELV = indicative occupational exposure limit values
Acute Tox. 3: Acute toxicity – Category 3
Acute Tox. 4: Acute toxicity – Category 4
Acute Tox. 2: Acute toxicity – Category 2
Skin Corr. 1B: Skin corrosion/irritation – Category 1B
Skin Irrit. 2: Skin corrosion/irritation – Category 2
Eye Dam. 1: Serious eye damage/eye irritation – Category 1
Eye Irrit. 2: Serious eye damage/eye irritation – Category 2
Skin Sens. 1: Skin sensitisation – Category 1
Skin Sens. 1A: Skin sensitisation – Category 1A
STOT RE 1: Specific target organ toxicity (repeated exposure) – Category 1
Aquatic Acute 1: Hazardous to the aquatic environment - acute aquatic hazard – Category 1
Aquatic Chronic 1: Hazardous to the aquatic environment - long-term aquatic hazard – Category 1
Aquatic Chronic 2: Hazardous to the aquatic environment - long-term aquatic hazard – Category 2
Aquatic Chronic 3: Hazardous to the aquatic environment - long-term aquatic hazard – Category 3
* Data compared to the previous version altered.
GB
56.0.15